Skip to content

Effect of Exercise Programs on 3-dimensional Scapular Kinematics, Disability and Pain

Effect of Exercise Programs on 3-dimensional Scapular Kinematics, Disability and Pain in Subjects With Shoulder Impingement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02286310
Enrollment
36
Registered
2014-11-07
Start date
2014-02-28
Completion date
2016-02-29
Last updated
2014-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Impingement Syndrome

Keywords

Exercise, Kinematics

Brief summary

The aim of this study is to investigate the effect of exercise program on 3-dimensional scapular kinematics, disability and pain on shoulder impingement with scapular dyskinesia.

Interventions

Exercises include kinetic chain segments.

Stretching, strengthening exercises.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Subacromial impingement with scapular dyskinesia

Exclusion criteria

* Additional muscular and skeletal or systemic diseases

Design outcomes

Primary

MeasureTime frameDescription
3-Dimensional Scapular Kinematics measured by electromagnetic tracking systemChange from Baseline in Angular Data at 1 yearScapular rotations and orientations in degrees

Secondary

MeasureTime frameDescription
Pain and Disability Status measured by Shoulder Pain and Disability Index (SPADI)Change from Baseline in Scor at 1 yearScoring with patient-reported outcome measure
Pain Severity measured by Visual Analogue Scale (in millimeters)Change from Baseline in Pain Severity at 1 yearScale is in millimeters

Countries

Turkey (Türkiye)

Contacts

Primary ContactElif Turgut, MSc
elifcamci@hacettepe.edu.tr00903123052525
Backup Contactİrem Düzgün, PhD
iremduzgun@yahoo.com00903123052525

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026